Kristina Matkowskyj

Gastric hyperplastic polyps causing upper gastrointestinal hemorrhage in a young adult.

Aldoketoreductase family 1B10 (AKR1B10) as a biomarker to distinguish hepatocellular carcinoma from benign liver lesions.

Phospholipid ether analogs for the detection of colorectal tumors.

Improved Detection of Microsatellite Instability in Early Colorectal Lesions.

Overactivation of the nuclear factor (erythroid-derived 2)-like 2-antioxidant response element pathway in hepatocytes decreases hepatic ischemia/reperfusion injury in mice.

Precision medicine in colorectal cancer: the molecular profile alters treatment strategies.

Colon Cancer Tumorigenesis Initiated by the H1047R Mutant PI3K.

Advanced Intestinal Cancers often Maintain a Multi-Ancestral Architecture.

Serrated polyps are detected at CT colonography: clinical observations over the past decade and results from CTC-based screening of average risk adults.

Subclonal diversity arises early even in small colorectal tumours and contributes to differential growth fates.

Dual PI3K/mTOR Inhibition in Colorectal Cancers with and Mutations.

Versican-Derived Matrikines Regulate Batf3-Dendritic Cell Differentiation and Promote T Cell Infiltration in Colorectal Cancer.

AKR1B10 expression by immunohistochemistry in surgical resections and fine needle aspiration cytology material in patients with cystic pancreatic lesions; potential for improved nonoperative diagnosis.

Restoration of metabolic health by decreased consumption of branched-chain amino acids.

Depth of Invasion Does Not Prognosticate Survival in T2 Esophageal Adenocarcinoma.

MTORC1/2 Inhibition as a Therapeutic Strategy for Mutant Cancers.

Molecular Profiles Guide Colorectal Cancer Treatment.

Patient-Derived Cancer Organoid Cultures to Predict Sensitivity to Chemotherapy and Radiation.

Implementation and Clinical Utility of an Integrated Academic-Community Regional Molecular Tumor Board.

Multi-ancestral origin of intestinal tumors: Impact on growth, progression, and drug efficacy.

PI3K/mTOR inhibition prevents anal cancer in mice with established low-grade anal dysplasia.

Stromal remodeling regulates dendritic cell abundance and activity in the tumor microenvironment.

Anal Cancer Prevention Through the Topical Use of Single or Dual PI3K/mTOR Inhibitors.

Growth rates and histopathological outcomes of small (6-9 mm) colorectal polyps based on CT colonography surveillance and endoscopic removal.

Preclinical Models of Anal Cancer Combined-Modality Therapy.

Dietary restriction of isoleucine increases healthspan and lifespan of genetically heterogeneous mice.